Associations of polymorphisms in the frzb gene with osteoporosis
CA 2521329 C · Owner: Li, Jia · Inventors: Ro, Sunhee Kwon; Fijal, Bonnie; Peltz, Gary Allen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and reagents for determining sequence variants present at the FRZB locus, which facilitate identifying individuals at risk for obesity and/or osteoporosis, are provided. In particular methods for detecting an , individual's risk for obesity and/or osteoporosis by detecting at least one polymorphism (e.g. at least one single nucleotide polymorphism) in the FRZB gene in a nucleic acid sample from the individual are provided. Related kits arrays and systems are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 20, 2004 and granted November 24, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 20, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 20, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.